Skip to content
Search

Latest Stories

RPS highlights workforce crisis in pharmacy to Welsh Parliament

The Royal Pharmaceutical Society (RPS) has informed the Welsh Parliament about the workforce crisis in the pharmacy sector and the need to prioritise staff well-being and training requirements to help Covid recovery plans.

Providing evidence to the Senedd’s Health and Social Care Committee’s inquiry into waiting times, the RPS director in Wales Elen Jones emphasised that the pandemic brought the pharmacy workforce under immense pressure.


She emphasised on “the need for workforce planning that allows pharmacists enough time to learn, teach and embed new skills,” which would help in maintaining a motivated and sustainable workforce.

Jones presented the evidence alongside colleagues from the Royal College of General Practitioners, Community Pharmacy Wales and the Royal College of Nursing.

She said: “Our key message to the committee was clear; while more can be done to harness the expert skills and knowledge of pharmacists, this must always be underpinned by proper workforce planning that accounts for workload pressures and builds in sufficient training time”.

Other points highlighted by Jones included:

  • The increase in the number of clinical services provided by community pharmacists.
  • The benefits of independent prescribing services and the required steps to take full advantage of prescribing pharmacists
  • The need for direct referral pathways to and from community pharmacies to other NHS services.
  • Emphasising that services such as NHS 111 should be better promoted to be public once services are universally available throughout Wales

“We look forward to the committee’s final report and recommendation and will continue to champion pharmacy’s role in the Senedd,” she added.

More For You

Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less
Three pharmacists named in NIHR’s latest cohort of senior investigators

L-R: Professor David Alldred; Professor Rachel Elliott and Professor Ian Maidment.

Three pharmacists appointed as NIHR senior investigators

The National Institute for Health and Care Research (NIHR) has announced its latest cohort of senior investigators, including three distinguished pharmacists.

David Alldred, professor of medicines use and safety at the University of Leeds; Rachel Elliott, professor of health economics at the University of Manchester; and Ian Maidment, professor in clinical pharmacy at Aston University, have been named in the list of 39 new appointments, alongside 19 reappointed senior investigators.

Keep ReadingShow less
Vaccine-preventable infections costing UK billions

Effective interventions are needed to prevent hospitalisations

Vaccine-preventable infections costing UK billions

Effective interventions are having a positive impact but more needs to be done to combat vaccine-preventable infections after data revealed today showed that it accounted for 20 per cent of hospital bed usage in the UK between 2023 to 2024 at a cost of almost £6 billion.

The return of social mixing, international travel and migration following the COVID-19 pandemic have contributed to the rise in both endemic disease and vaccine-preventable infections, according to the UK Health Security Agency's (UKHSA).

Keep ReadingShow less